In a 12-week randomized controlled trial, participants with prediabetes who consumed 180 mg of curcumin daily had significantly reduced GSK3β and IAPP in serum samples after 12 weeks compared with placebo groups, reducing insulin resistance and the risk of developing AD and DM (Thota et al., 2020). The gene discussed is GSK3B; the disease is Alzheimer disease.